A new anti-cancer drug in the market: Good news for investors or for patients?

Giovanni Apolone, Giovanni Tafuri, Francesco Trotta, Silvio Garattini

Research output: Contribution to journal › Article

@article{1a6d9fce49b04117974e250cad327f69,

title = "A new anti-cancer drug in the market: Good news for investors or for patients?",

author = "Giovanni Apolone and Giovanni Tafuri and Francesco Trotta and Silvio Garattini",

year = "2008",

month = "9",

doi = "10.1016/j.ejca.2008.06.021",

language = "English",

volume = "44",

pages = "1786--1788",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

number = "13",

}

TY - JOUR

T1 - A new anti-cancer drug in the market

T2 - Good news for investors or for patients?

AU - Apolone, Giovanni

AU - Tafuri, Giovanni

AU - Trotta, Francesco

AU - Garattini, Silvio

PY - 2008/9

Y1 - 2008/9

UR - http://www.scopus.com/inward/record.url?scp=49549095319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49549095319&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2008.06.021

DO - 10.1016/j.ejca.2008.06.021

M3 - Article

C2 - 18672359

AN - SCOPUS:49549095319

VL - 44

SP - 1786

EP - 1788

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 13

ER -